Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: Phase 3, randomized, vehicle-controlled study (CAPTAIN-AD)
- Abstract
- -----------e-pub(22.1.12)----
This current study aimed to evaluate the efficacy and safety of asivatrep cream in patients with AD.
- Issued Date
- 2021
- Type
- Article
- Keyword
- Abridged Index Medicus; asivatrep; Atopic dermatitis; pruritus; transient receptor potential vanilloid subfamily member 1 (TRPV1)
- URI
- https://oak.ulsan.ac.kr/handle/2021.oak/8246
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_proquest_miscellaneous_2579377251&context=PC&vid=ULSAN&lang=ko_KR&search_scope=default_scope&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,Asivatrep,%20a%20TRPV1%20antagonist,%20for%20the%20topical%20treatment%20of%20atopic%20dermatitis:%20Phase%203,%20randomized,%20vehicle-controlled%20study%20(CAPTAIN-AD)&offset=0&pcAvailability=true
- Publisher
- JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Location
- 미국
- Language
- 영어
- ISSN
- 0091-6749
- Citation Volume
- 11
- Citation Number
- 11
- Citation Start Page
- 1
- Citation End Page
- 12
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.